NovoCure (NVCR) Assets Average (2015 - 2026)

NovoCure's Assets Average history runs 12 years deep, the most recent figure standing at $796.1 million for Q1 2026.

• In Q1 2026, Assets Average fell 36.04% year-over-year to $796.1 million; the TTM figure through Mar 2026 stood at $796.1 million (down 36.04% YoY), while the FY2025 annual figure was $1.0 billion, down 14.32% from the prior year.
• Assets Average came in at $796.1 million for Q1 2026 at NovoCure, down from $1.1 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q3 2025 to a low of $796.1 million in Q1 2026.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average rose 9.79% in 2025 and slumped 36.04% in 2026, its largest moves.
• NovoCure's Assets Average stood at $1.2 billion in 2022, then retreated by 3.1% to $1.1 billion in 2023, then increased by 7.43% to $1.2 billion in 2024, then retreated by 12.07% to $1.1 billion in 2025, then slipped by 26.47% to $796.1 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $796.1 million, $1.1 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison